ScholarGate
Assistente

Genetic Carrier Screening in Pregnancy

Genetic carrier screening identifies prospective or current parents who carry a variant for a recessive or X-linked condition without being affected themselves. When both partners carry a variant in the same recessive gene, or a person carries an X-linked variant, the fetus may be at risk, and screening provides information for reproductive counselling before or during pregnancy.

Trova un argomento con PaperMindIn arrivoFind papers & topics
Tools & resources
Scarica le diapositive
Learn & explore
VideoIn arrivo

Definition

Genetic carrier screening is testing of prospective or current parents to identify carriers of recessive or X-linked disease variants, so that couples in whom the fetus is at increased risk of an inherited condition can be identified and offered counselling and, if desired, diagnostic testing.

Scope

This topic covers the purpose and types of carrier screening, including ethnicity-based, panethnic, and expanded panel approaches, and how carrier results inform reproductive risk. It frames carrier screening as identification of inherited risk, distinct from fetal aneuploidy and structural anomaly screening, and is non-prescriptive about individual decisions.

Core questions

  • What does carrier screening detect and why?
  • How do ethnicity-based, panethnic, and expanded carrier screening differ?
  • How is reproductive risk determined from parental carrier status?
  • How does carrier screening relate to prenatal diagnosis?

Key concepts

  • Carrier (heterozygote) status
  • Autosomal recessive inheritance
  • X-linked inheritance
  • Ethnicity-based screening
  • Panethnic and expanded carrier screening
  • Reproductive risk and counselling
  • Residual risk

Mechanisms

Carrier screening tests parental DNA for pathogenic variants in genes associated with recessive or X-linked conditions. For an autosomal recessive condition, a fetus is at risk only when both biological parents carry a variant in the same gene, giving a one-in-four risk per pregnancy in that situation; for X-linked conditions, a carrier mother confers risk to male offspring. Screening can be targeted by ancestry for conditions concentrated in particular populations, offered panethnically for common conditions such as cystic fibrosis and spinal muscular atrophy, or delivered as expanded panels covering many genes simultaneously. A positive result identifies reproductive risk and is followed by counselling and the option of prenatal or preimplantation diagnostic testing (ACOG, 2017).

Clinical relevance

Carrier screening shows how inherited reproductive risk is identified before it manifests in a fetus, and how this information feeds into counselling and the offer of diagnostic testing. This entry describes the method and its interpretation at a population level and is not a basis for individual reproductive or treatment decisions.

Epidemiology

Carrier frequencies for individual recessive conditions vary by ancestry, and the yield of screening depends on the conditions included and the population tested. Professional guidance has moved toward offering screening for common conditions to all pregnant or prospective patients while recognizing that no panel detects every variant, leaving a residual risk (ACOG, 2017).

History

Carrier screening began with single-condition, ancestry-targeted programmes such as Tay-Sachs disease screening in the late twentieth century. The advent of multiplex and sequencing technologies enabled panethnic and expanded panels, prompting professional bodies to reconsider how broadly screening should be offered.

Debates

Ethnicity-based versus expanded carrier screening
Ethnicity-based screening targets conditions concentrated in defined populations, whereas expanded panels test many genes regardless of ancestry; debate concerns which approach best balances detection, equity across ancestries, interpretive complexity, and counselling burden.

Related topics

Seminal works

  • acog-2017-co691

Frequently asked questions

Does a positive carrier result mean the fetus is affected?
No. Being a carrier means a person is usually unaffected but can pass on a variant; a fetus is at increased risk only when the inheritance pattern is met, such as both parents carrying a variant in the same recessive gene, and confirmation requires diagnostic testing.
What is expanded carrier screening?
Expanded carrier screening tests for variants in many genes at once regardless of ancestry, in contrast to ethnicity-based screening that targets conditions common in specific populations.

Methods for this concept

Related concepts